Si-Bone (SIBN) Revenue Growth (1y) (2018 - 2026)
Si-Bone (SIBN) Revenue Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn | 6.08% |
| 10 | Si-Bone | 751.27 Mn | 606.59 Mn | 41.94 Mn | 11.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.20% |
| Dec 31, 2025 | 14.99% |
| Sep 30, 2025 | 20.61% |
| Jun 30, 2025 | 21.67% |
| Mar 31, 2025 | 24.88% |
| Dec 31, 2024 | 26.10% |
| Sep 30, 2024 | 18.60% |
| Jun 30, 2024 | 20.01% |
| Mar 31, 2024 | 15.77% |
| Dec 31, 2023 | 21.61% |
| Sep 30, 2023 | 28.68% |
| Jun 30, 2023 | 30.17% |
| Mar 31, 2023 | 45.76% |
| Dec 31, 2022 | 26.65% |
| Sep 30, 2022 | 18.60% |
| Jun 30, 2022 | 15.28% |
| Mar 31, 2022 | 9.77% |
| Dec 31, 2021 | 13.94% |
| Sep 30, 2021 | 9.39% |
| Jun 30, 2021 | 57.98% |